---
title: 'Associate Director, Omnichannel Marketing at Iovance Biotherapeutics'
canonical: 'https://feeny.ai/job/associate-director-omnichannel-marketing-iovance-biotherapeutics-remote-cj02etnvh9s0'
type: 'job'
last_seen: '2026-10-29'
---

# Associate Director, Omnichannel Marketing at Iovance Biotherapeutics

- **Company:** Iovance Biotherapeutics
- **Location:** Remote
- **Compensation:** $200k–$215k
- **Work type:** remote
- **Posted:** 2026-10-15
- **Last confirmed live:** 2026-10-29
- **Apply:** https://job-boards.greenhouse.io/iovancebiotherapeutics/jobs/5453325008

## Job description

About Iovance Biotherapeutics, Inc.

[Iovance Biotherapeutics](https://www.iovance.com/), Inc.  is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The [Iovance TIL platform](https://www.iovance.com/our-science/til-platform/) spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit [www.iovance.com](http://www.iovance.com/).

Amtagvi® and its accompanying design marks, Proleukin®, Iovance®, and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or

ts subsidiaries. All other trademarks and registered trademarks are the property of their respective owners.

Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on [www.iovance.com](http://www.iovance.com/).

## Overview

The Associate Director, Omnichannel Marketing will lead integrated omnichannel planning, media investment, and non-personal promotion for healthcare professional (HCP), patient, and caregiver audiences. In partnership with HCP and Patient Marketing leads, this role translates brand strategy and customer insights into coordinated engagement plans across digital and media channels, with accountability for campaign delivery, budget management, measurement, and continuous improvement. This hands-on role combines strategic leadership with execution, guiding agencies and cross-functional partners from planning through compliant deployment and optimization. The position offers the opportunity to build and scale digital engagement capabilities that support education and relevant customer experiences in oncology and cell therapy.

Essential Functions and Responsibilities

- Lead annual omnichannel marketing planning for assigned initiatives, translating brand priorities into audience strategies, channel plans, investment recommendations, timelines, and measurable objectives.
- Partner with HCP and Patient Marketing leads to align omnichannel initiatives with brand strategy, market research, customer needs, and business priorities; recommend trade-offs and priorities within approved plans and budgets.
- Design coordinated HCP engagement journeys that connect relevant content, channels, timing, and follow-up; partner with Commercial teams to align non-personal promotion with field engagement where appropriate.
- Lead patient and caregiver engagement planning and execution, using journey insights to deliver relevant disease-state education and approved branded communications that address information needs across the treatment consideration journey.
- Translate customer insights and audience segmentation into campaign briefs, content requirements, and coordinated activation plans; maintain consistent messaging and manage delivery milestones across channels.
- Lead media and digital agency partners through planning, execution, and optimization across programmatic media, paid search, paid social, websites, and email/customer relationship management (CRM) campaigns, as appropriate to the audience and approved plan. Establish clear briefs, scopes of work, deliverables, and performance expectations.
- Partner with business leads and analytics colleagues to establish measurement plans, key performance indicators, and dashboards before campaign launch. Evaluate reach, audience engagement, journey progression, and investment efficiency; communicate insights and optimization recommendations to stakeholders, recognizing the limits of attribution.
- Develop and execute test-and-learn plans across audience targeting, content, channel mix, and communication timing; use findings to improve customer experiences and recommend campaign and investment adjustments.
- Evaluate emerging digital capabilities, including artificial intelligence, against defined business needs. Partner with technology, analytics, and compliance colleagues to assess feasibility, data requirements, privacy, and implementation priorities before adoption.
- Serve as content owner through the promotional review process, partnering with Medical, Legal, and Regulatory reviewers to manage assets from development through approval, deployment, updates, and retirement. Maintain approval status and channel readiness without assuming reviewers’ approval authority.
- Lead cross-functional delivery with Marketing, Commercial, Medical Affairs, Market Access, Legal, analytics, and technology partners while respecting functional responsibilities. Ensure campaigns follow applicable promotional, privacy, consent, and company requirements, including established safety-reporting processes for digital channels.
- Own the assigned omnichannel and media execution budget, including forecasting, spend tracking, agency scope management, and reconciliation. Recommend resource allocation and adjustments based on campaign performance, business priorities, and measurable investment
- Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics.
- Perform miscellaneous duties as assigned.

Travel - up to 30% (domestic)

Required Education, Skills, and Knowledge

- 10+ years of progressively responsible experience in the pharmaceutical or biotechnology industry, including demonstrated ownership of marketing initiatives and cross-functional delivery.
- Within that experience, 5+ years in U.S. commercial pharmaceutical or biotechnology marketing, product management, omnichannel marketing, or related commercial roles, with substantial hands-on responsibility for digital campaigns and media.
- A bachelor’s degree in marketing, life sciences, or a related field is required.
- Preferred: Oncology or cell therapy marketing experience; experience supporting marketed brands, product launches, or complex treatment and referral journeys.
- Demonstrated success leading integrated omnichannel and non-personal promotional campaigns from audience segmentation and journey planning through execution, measurement, and optimization. Able to explain personal ownership, investment decisions, and measurable results.
- Demonstrated ability to lead cross-functional initiatives and agency partners without direct reporting authority, manage budgets and competing priorities, and deliver in a lean, fast-paced environment.
- Experience with programmatic media, paid social, paid search, and email/CRM across HCP and patient audiences, plus media measurement and attribution tools. Working knowledge of websites, marketing automation, audience data, and how channels connect across the customer journey.
- Strong strategic judgment and analytical skills, with the ability to turn customer insights and campaign data into clear priorities, investment recommendations, and actionable plans.
- Ability to learn complex scientific and commercial information, navigate ambiguity, and apply sound judgment when evaluating emerging digital approaches.
- Hands-on experience with pharmaceutical Medical, Legal, and Regulatory promotional review and compliant content deployment, including working knowledge of digital privacy, consent, and applicable company safety-reporting procedures.
- Strong relationship-building and influencing skills, with the ability to resolve competing priorities and build consensus across functions and levels.
- Ability to operate independently while collaborating closely with business partners, balancing strategic planning with hands-on execution and accountability for results.
- Excellent written, verbal, and presentation skills, including the ability to communicate campaign results, business implications, and recommendations clearly to senior stakeholders.

Physical Demands and Activities Required

The physical demands described here represent those an employee may encounter while performing the essential functions of this job. Reasonable accommodation may be provided to enable individuals to perform these functions.

- Ability to remain in a stationary position for extended periods
- Ability to move about within an office or remote workspace and exert up to 10 pounds of force occasionally
- Visual acuity sufficient for preparing and analyzing data, viewing computer screens, and extensive reading
- Repetitive motion involving wrists, hands, and/or fingers
- Ability to communicate effectively to exchange information
- Ability to engage in analytical, conceptual, and problem‑solving activities in a dynamic business environment

Mental: Clear and conceptual thinking ability; excellent judgment, troubleshooting, problem-solving, analysis, and discretion; ability to handle work-related stress; ability to handle multiple priorities simultaneously with a sense of urgency; and ability to meet deadlines

Work Environment

This job operates in a professional or remote office environment and requires operating standard office equipment and keyboards.

#li-remote The annual base salary we reasonably expect to pay is listed. Individual pay decisions depend on various factors, such as primary work location, complexity and responsibility of the role, job duties/requirements, and relevant education, experience and skills.

Pay Transparency $200,000—$215,000 USD

The statements contained in this document are intended to describe the general nature and level of work being performed by a colleague assigned to this description. They are not intended to constitute a comprehensive list of functions, duties, or local variances. Management retains the discretion to add or to change the duties of the position at any time.

Iovance is committed to cultivating and offering a diverse and inclusive work environment. As an equal-opportunity employer, our employees and applicants will be considered without regard to an individual’s race, color, religion, sex, pregnancy, national origin, age, physical and mental disability, marital status, sexual orientation, gender identity, gender expression, genetic information, military and veteran status, and any other characteristic protected by applicable law. If you need assistance or accommodation to apply to one of our opportunities, please contact careers@iovance.com.

By voluntarily providing information and clicking “Submit Application”, you explicitly consent to the collection and use of your personal information for the purposes described above and in our [Candidate Privacy Notice](https://www.iovance.com/privacy-policy/).

## About Iovance Biotherapeutics

## Company Overview
- **One-liner**: Iovance Biotherapeutics is pioneering tumor infiltrating lymphocyte (TIL) cell therapies to develop personalized, one-time treatments for solid tumor cancers.
- **Entity Type**: Public (NASDAQ: IOVA)
- **Headquarters**: San Carlos, California, USA
- **Founded**: 2007 (originally named Lion Biotechnologies, renamed Iovance Biotherapeutics in 2017)
- **Founders**: Not publicly available (the company was formed through a merger and rebranding)

## Core Business
- **Primary industry**: Biotechnology — Cell Therapy (Immuno-Oncology)
- **Target customers**: B2B / B2G — Healthcare providers, clinical trial sites, and ultimately patients with advanced solid tumors (melanoma, non-small cell lung cancer, endometrial cancer, etc.)
- **Mission or purpose statement**: To be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer, harnessing the immune system to recognize and attack diverse cancer cells.

## Products & Services
- **Lifileucel (IOV-009)**: A one-time, personalized TIL therapy for advanced melanoma. It is the first approved TIL therapy for a solid tumor (FDA approved in early 2024 under the brand name Amtagvi).
- **IOV-LUN-202**: An investigational TIL therapy for advanced non-small cell lung cancer (NSCLC) currently in Phase 2 clinical trials.
- **IOV-END-201**: An investigational TIL therapy for advanced endometrial cancer currently in Phase 2 clinical trials.
- **IOV-4001**: A next-generation, gene-edited TIL therapy (using TALEN technology to inactivate PD-1 expression) for solid tumors, currently in preclinical/early clinical development.
- **IOV-3001**: An engineered IL-2 therapy (licensed from Novartis) designed to support TIL therapy efficacy, currently in preclinical development.
- **Cell Therapy Manufacturing (iCTC)**: The company operates a 136,000-square-foot, state-of-the-art Cell Therapy Center in Philadelphia, PA, for proprietary GMP manufacturing of TIL therapies.

## Market Standing
- **Valuation/Market Cap**: As of early 2026, market capitalization is approximately $2.5–3.0 billion (fluctuates with FDA news and clinical data). Check current price on NASDAQ: IOVA.
- **Key Metric (Revenue)**: Iovance generated its first commercial revenue from Lifileucel/Amtagvi in 2024. Annual revenue for 2025 was approximately $180–220 million (estimate based on analyst reports; exact figure not yet fully disclosed). The company is not yet profitable.
- **Key Metric (Funding)**: As a public company, Iovance has raised over $1.5 billion through public offerings and debt financings. Notable recent raise: a public offering in 2022 and subsequent at-the-market offerings.
- **Notable Investors/Partners**:
    - Novartis (license partner for IOV-3001)
    - Major institutional investors (e.g., BlackRock, Vanguard, and several healthcare-focused funds)
    - Collaborations with major cancer centers for clinical trials (e.g., MD Anderson, Memorial Sloan Kettering, etc.)
- **Growth Signals**:
    - FDA approval of Lifileucel (Amtagvi) in early 2024 — a landmark first-in-class approval for TIL therapy in solid tumors.
    - Rapid commercial launch and expansion of treatment centers across the U.S.
    - Multiple ongoing Phase 2/3 trials in large indications (NSCLC, endometrial cancer, frontline melanoma).
    - Investment in next-generation gene-edited TIL (IOV-4001) and engineered IL-2 (IOV-3001) to improve efficacy and expand addressable patient populations.

## Competitive Advantages
- **First-to-market TIL therapy**: Iovance is the only company with an FDA-approved TIL therapy for a solid tumor (Amtagvi for melanoma), giving it a significant head start in manufacturing, commercial infrastructure, and physician education.
- **Proprietary manufacturing platform**: The in-house iCTC facility in Philadelphia enables scalable, standardized GMP production of personalized TIL therapies, a major barrier to entry for competitors.
- **Broad solid tumor pipeline**: Unlike CAR-T therapies (primarily effective in blood cancers), TIL therapy has shown promise across multiple solid tumor types, providing a large addressable market.
- **Polyclonal T cell approach**: The therapy targets a broad range of neoantigens unique to each patient’s tumor, potentially reducing the risk of immune escape compared to single-target therapies.

## Strategic Focus
- **Commercial expansion**: Scaling up the launch of Amtagvi for advanced melanoma and expanding treatment center network globally.
- **Pipeline acceleration**: Advancing pivotal trials in NSCLC (IOV-LUN-202) and endometrial cancer (IOV-END-201) to secure additional FDA approvals.
- **Next-generation innovation**: Developing gene-edited TIL (IOV-4001) to enhance persistence and efficacy, and engineered IL-2 (IOV-3001) to improve the TIL therapy cycle.
- **Manufacturing optimization**: Continuing to improve manufacturing efficiency and turnaround time at the iCTC facility to support growing demand and reduce costs.

## Why Work Here
- **Mission-driven culture**: The company is deeply patient-centric, with a clear focus on delivering transformative therapies to cancer patients. Employees often cite the meaningful impact of their work as a key motivator.
- **Values**: Integrity, agility, innovation, collaboration, and excellence are core to the company’s operating philosophy. The culture emphasizes transparency, teamwork, and high ethical standards.
- **Diversity, Equity, and Inclusion**: Iovance has a stated commitment to DEI, recognizing that internal diversity is critical to serving diverse patient populations and driving innovation.
- **Remote/Hybrid policy**: Many roles (especially in clinical, medical affairs, marketing, and commercial functions) are remote or hybrid. Laboratory and manufacturing roles are based on-site in Philadelphia, PA (iCTC) or San Carlos, CA (HQ).
- **Benefits**: Competitive salaries, annual cash bonuses, long-term incentives (stock options/RSUs), 401(k) with match, Employee Stock Purchase Plan, comprehensive medical/dental/vision (low employee cost), Health Savings Account contributions, paid parental leave, tuition assistance, wellness program (gym discounts), and professional development opportunities.
- **Work environment**: Agile and fast-paced, typical of a biotech company at a critical growth stage. The company values data-driven decision-making and encourages employees to bring their best efforts every day.

## Sources
1. [iovance.com](https://www.iovance.com/)
2. [iovance.com - About Us](https://www.iovance.com/about-iovance-biotherapeutics/)
3. [iovance.com - Culture](https://www.iovance.com/culture/)
4. [job-boards.greenhouse.io](http://job-boards.greenhouse.io/iovancebiotherapeutics)

## Other roles at Iovance Biotherapeutics

- [Manager, US Commercial Analytics](https://feeny.ai/job/manager-us-commercial-analytics-iovance-biotherapeutics-remote-pp175wb1c3rg)
- [Scientific Director, Medical Affairs](https://feeny.ai/job/scientific-director-medical-affairs-iovance-biotherapeutics-remote-hw991kwkzz0n)
- [Associate Director, Clinical Operations](https://feeny.ai/job/associate-director-clinical-operations-iovance-biotherapeutics-remote-x88j1h7q322y)
- [Senior Director, Pipeline Commercial Strategy](https://feeny.ai/job/senior-director-pipeline-commercial-strategy-iovance-biotherapeutics-remote-925a5g5qa15d)
- [Senior Director, Program Team Lead](https://feeny.ai/job/senior-director-program-team-lead-iovance-biotherapeutics-remote-kyypj1s0kgtv)
- [Director, U.S Customer Engagement, Strategic Alliances and Advocacy](https://feeny.ai/job/director-u-s-customer-engagement-strategic-alliances-and-advocacy-iovance-qt2mm7vmxfdf)
- [Clinical Trial Manager](https://feeny.ai/job/clinical-trial-manager-iovance-biotherapeutics-remote-gn64jtz5q07s)
- [Computer Systems Validation Analyst II](https://feeny.ai/job/computer-systems-validation-analyst-ii-iovance-biotherapeutics-remote-4y2b855y8stg)
- [Cell Therapy Account Management - North Central ( Preferred location Nebraska)](https://feeny.ai/job/cell-therapy-account-management-north-central-preferred-location-nebraska-jwja6gmgb87q) — Nebraska North Dakota South Dakota and, IA
- [Senior Director, Authorized Treatment Center (ATC) Cell Therapy Operations](https://feeny.ai/job/senior-director-authorized-treatment-center-atc-cell-therapy-operations-iovance-m8eq9271825v)